Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 18/20 | 0.89 |
| ▸ | BCL2L1 | Q07817 | 13/20 | 0.89 |
| ▸ | BCL2L2 | Q92843 | 3/20 | 0.56 |
| ▸ | BAD | Q92934 | 2/20 | 0.49 |
| ▸ | MDM4 | O15151 | 1/20 | 0.49 |
| ▸ | BCL2L11 | O43521 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | BID | P55957 | 1/20 | 0.49 |
| ▸ | BAX | Q07812 | 1/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.49 |
| ▸ | ASPH | Q12797 | 1/20 | 0.49 |
| ▸ | BECN1 | Q14457 | 1/20 | 0.49 |
| ▸ | BAK1 | Q16611 | 1/20 | 0.49 |
| ▸ | BBC3 | Q9BXH1 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9951702 | 0.94 | BCL2 (0.92) | BCL2BCL2L1BCL2L2BADMDM4 | |
| SCHEMBL9951660 | 0.94 | BCL2 (1.00) | BCL2BCL2L1BCL2L2 | |
| SCHEMBL9951655 | 0.94 | BCL2 (1.00) | BCL2BCL2L1BCL2L2 | |
| SCHEMBL9951825 | 0.93 | BCL2 (0.85) | BCL2BCL2L1BCL2L2BADMDM4 | |
| SCHEMBL9951816 | 0.93 | BCL2 (0.85) | BCL2BCL2L1BCL2L2BADMDM4 | |
| SCHEMBL9951357 | 0.89 | BCL2 (1.00) | BCL2BCL2L1BCL2L2 | |
| SCHEMBL9951352 | 0.89 | BCL2 (1.00) | BCL2BCL2L1BCL2L2 | |
| SCHEMBL9952191 | 0.88 | BCL2 (0.89) | BCL2BCL2L1BCL2L2 | |
| SCHEMBL9951713 | 0.88 | BCL2 (0.89) | BCL2BCL2L1BCL2L2 | |
| SCHEMBL9952181 | 0.88 | BCL2 (0.89) | BCL2BCL2L1BCL2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8809352-B2 | Sulfonamides as inhibitors of Bcl-2 family proteins for the treatments of cancer | NOVARTIS AG (CH) | 2014-08-19 | — | — | US | disclosed |